198 related articles for article (PubMed ID: 7695302)
41. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
[TBL] [Abstract][Full Text] [Related]
42. [Investigation of mupirocin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates by phenotypic and genotypic methods].
Us T; Kural M; Yayla B; Kiremitçi A; Cetin E; Akgün Y
Mikrobiyol Bul; 2009 Jul; 43(3):353-64. PubMed ID: 19795610
[TBL] [Abstract][Full Text] [Related]
43. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance.
Hill RL; Casewell MW
Drugs Exp Clin Res; 1990; 16(8):397-402. PubMed ID: 2129029
[TBL] [Abstract][Full Text] [Related]
44. Cohorting based on nasal methicillin-resistant Staphylococcus aureus status: an opportunity to share more than a room.
Kabbani D; Weir SK; Berg G; Chien GC; Strymish J; Gupta K
Am J Infect Control; 2013 May; 41(5):401-4. PubMed ID: 23499508
[TBL] [Abstract][Full Text] [Related]
45. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections.
Wilcox MH; Hall J; Pike H; Templeton PA; Fawley WN; Parnell P; Verity P
J Hosp Infect; 2003 Jul; 54(3):196-201. PubMed ID: 12855234
[TBL] [Abstract][Full Text] [Related]
46. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride.
Rohr U; Mueller C; Wilhelm M; Muhr G; Gatermann S
J Hosp Infect; 2003 Aug; 54(4):305-9. PubMed ID: 12919762
[TBL] [Abstract][Full Text] [Related]
47. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
Semret M; Miller MA
Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus nasal carriage in the West of Iran: a population-based cross-sectional study.
Ahmadi E; Khojasteh M; Mortazavi SM; Khan-Mohammadi F; Kazemnia A; Beheshtipour J; Raeeszadeh M
BMC Infect Dis; 2019 Oct; 19(1):899. PubMed ID: 31660878
[TBL] [Abstract][Full Text] [Related]
49. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets.
Loeffler A; Baines SJ; Toleman MS; Felmingham D; Milsom SK; Edwards EA; Lloyd DH
J Antimicrob Chemother; 2008 Dec; 62(6):1301-4. PubMed ID: 18819974
[TBL] [Abstract][Full Text] [Related]
50. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Staphylococcus aureus eradication therapy in orthopaedic surgery.
Tsang STJ; McHugh MP; Guerendiain D; Gwynne P; Boyd J; Laurenson IF; Templeton KE; Lewis S; Simpson AHRW; Walsh TS
J Med Microbiol; 2018 Jun; 67(6):893-901. PubMed ID: 29671723
[TBL] [Abstract][Full Text] [Related]
52. Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.
Camus C; Sebille V; Legras A; Garo B; Renault A; Le Corre P; Donnio PY; Gacouin A; Perrotin D; Le Tulzo Y; Bellissant E
Infection; 2014 Jun; 42(3):493-502. PubMed ID: 24464791
[TBL] [Abstract][Full Text] [Related]
53. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
[TBL] [Abstract][Full Text] [Related]
54. A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization.
Dryden MS; Dailly S; Crouch M
J Hosp Infect; 2004 Apr; 56(4):283-6. PubMed ID: 15066738
[TBL] [Abstract][Full Text] [Related]
55. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
56. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.
Gillett AP; Johnson T; Orton C; Wills R; Menday AP; Talbot DJ
J R Coll Gen Pract; 1984 May; 34(262):255-7. PubMed ID: 6737360
[TBL] [Abstract][Full Text] [Related]
57. Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.
Kiefer A; Bogdan C; Melichar VO
BMC Pulm Med; 2018 Jan; 18(1):20. PubMed ID: 29370836
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit.
Safdar N; Marx J; Meyer NA; Maki DG
Am J Infect Control; 2006 Oct; 34(8):476-83. PubMed ID: 17015152
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients.
Souly K; Ait el kadi M; Lahmadi K; Biougnach H; Boughaidi A; Zouhdi M; Benasila S; Elyoussefi Z; Bouattar T; Zbiti N; Skalli Z; Rhou H; Ouzeddoun N; Bayahia R; Benamar L
Med Mal Infect; 2011 Sep; 41(9):469-74. PubMed ID: 21752563
[TBL] [Abstract][Full Text] [Related]
60. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.
Miller MA; Dascal A; Portnoy J; Mendelson J
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):811-3. PubMed ID: 8985769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
